Comparative Pharmacology
Head-to-head clinical analysis: STIMATE versus STIMATE NEEDS NO REFRIGERATION.
Peer-Reviewed Evidence
Head-to-head clinical analysis: STIMATE versus STIMATE NEEDS NO REFRIGERATION.
STIMATE vs STIMATE (NEEDS NO REFRIGERATION)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Desmopressin acetate is a synthetic analog of the natural pituitary hormone 8-arginine vasopressin (ADH). It acts as a V2 receptor agonist in the renal collecting ducts, increasing water permeability and promoting water reabsorption, thereby reducing urine output. It also increases plasma levels of von Willebrand factor and factor VIII via V2 receptor stimulation on endothelial cells.
Desmopressin is a synthetic analogue of vasopressin (antidiuretic hormone) that increases cyclic AMP levels in renal collecting duct cells, enhancing water reabsorption and concentrating urine. It also raises plasma levels of von Willebrand factor and factor VIII by stimulating release from endothelial stores.
Intranasal: 1 spray (1.5 mg) into one nostril, 1 hour prior to voiding or on awakening for bedwetting; maximum 2 sprays per day.
Intranasal: 1 spray (1.5 mg) into one nostril; may repeat once after 30-60 minutes if needed. Not to exceed 2 doses per bleeding episode.
None Documented
None Documented
Clinical Note
moderateNorgestimate + Atazanavir
"The serum concentration of Atazanavir can be increased when it is combined with Norgestimate."
Clinical Note
moderateNorgestimate + Fosamprenavir
"The serum concentration of the active metabolites of Fosamprenavir can be reduced when Fosamprenavir is used in combination with Norgestimate resulting in a loss in efficacy."
Clinical Note
moderateNorgestimate + Cobicistat
"The serum concentration of Cobicistat can be increased when it is combined with Norgestimate."
Clinical Note
moderateTerminal elimination half-life is approximately 3-4 hours in healthy adults, but may be prolonged in patients with renal impairment or in older adults.
Terminal elimination half-life is 2-4 hours (mean 3 hours), which supports a dosing interval of 2-4 hours in clinical use.
Desmopressin is primarily excreted renally, with approximately 60-70% of the dose recovered unchanged in urine within 24 hours. The remaining fraction is metabolized hepatically and eliminated via feces.
Renal excretion of intact drug and metabolites accounts for >90% of elimination; biliary/fecal excretion is minimal (<5%).
Category C
Category C
Antidiuretic Hormone Analog
Antidiuretic Hormone Analog
Norgestimate + Boceprevir
"The serum concentration of Boceprevir can be increased when it is combined with Norgestimate."